Mark van den Bosch was born in Klimmen, Limburg, the Netherlands, in 1992. He received his B.Sc. degree in Chemical Engineering and Chemistry at the Eindhoven University of Technology in 2014. During his B.Sc. degree, Mark did his bachelor project on “the synthesis and testing of new partial agonists for the RXRα nuclear receptor”, under the supervision of Prof. Dr. Ir. L. Brunsveld. Currently, he is doing his graduation project at the Noël Research Group.